Advertisement
Screener

Denali Therapeutics Inc. (DNLI) Net Margin

Denali Therapeutics Inc. (DNLI) Net Margin

  • 2026-06-30: Net Margin -3539.21%.
  • 2023-09-30: Net Margin -7841.59%.
  • 2023-06-30: Net Margin 62.35%.
  • 2023-03-31: Net Margin -312.40%.

Complete source-backed net margin history.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-3539.21%
2023-09-30-7841.59%
2023-06-3062.35%
2023-03-31-312.40%
2022-12-31-961.77%
2022-09-30-56140.76%
2022-06-30-112.03%
2022-03-31-154.77%
2021-12-31-601.41%
2021-09-30-1600.53%
2021-06-30-264.61%
2021-03-31-884.13%
2020-12-3177.30%
2020-09-30-620.24%
2020-06-30-1011.15%
2020-03-31-1598.06%
2019-12-31-1173.69%
2019-09-30-342.46%
2019-06-30-1423.55%
2019-03-31-948.48%
2018-12-3161.72%
2018-09-30-2959.92%
2018-06-30-3320.63%
2018-03-31-3693.92%

Annual Net Margin

DateNet Margin
2023-12-31-43.94%
2022-12-31-310.28%
2021-12-31-597.20%
2020-12-3121.20%
2019-12-31-750.81%
2018-12-31-28.07%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Greenland Mines Ltd (GRML)United States$2.362B
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Adaptive Biotechnologies Corp (ADPT)United States$4.719B-53.43